Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Tick-borne encephalitis vaccine
- Development stage
- Approved
- Lead developer
- Pfizer
- Modality
- Whole Inactivated Vaccines → Inactivated Vaccines → Prophylactic Vaccines → Vaccines & Immunotherapeutics
- Administration
- Intramuscular
01
Overview
Tick-borne encephalitis vaccine is an inactivated viral vaccine used for active immunization to prevent tick-borne encephalitis (TBE), a potentially severe viral infection transmitted by ticks and endemic in parts of Europe and Asia. The vaccine works by inducing the production of neutralizing antibodies against the tick-borne encephalitis virus (TBEV), providing immunity before exposure. It is administered as a three-dose series with periodic booster doses recommended for ongoing risk. The World Health Organization recommends vaccination for all people in highly endemic areas and those at high risk elsewhere. Several formulations exist globally; TICOVAC (Pfizer) is approved in the United States, while FSME-Immun (Pfizer) and Encepur (GSK) are widely used in Europe. Russian-manufactured vaccines include EnceVir and TBE-Moscow[1][4][5][6][8].
- Brand names
- FSME-ImmunEncepurTICOVACEnceVirTBE-Moscow
- Other names
- TBE vaccine
Beyond the preview
Go deeper on Tick-borne encephalitis vaccine.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Tick-borne encephalitis vaccine.